Neural Regeneration Research ›› 2013, Vol. 8 ›› Issue (21): 1948-1957.doi: 10.3969/j.issn.1673-5374.2013.21.003

Previous Articles     Next Articles

Is X-linked methyl-CpG binding protein 2 a new target for the treatment of Parkinson’s disease?

Teng Xie1, Jie Zhang1, Xianhou Yuan1, Jing Yang2, Wei Ding1, Xin Huang1, Yong Wu1   

  1. 1 Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China
    2 Department of Pharmacology, Wuhan University School of Medicine, Wuhan 430071, Hubei Province, China
  • Received:2013-03-18 Revised:2013-05-15 Online:2013-07-25 Published:2013-07-25
  • Contact: Xianhou Yuan, Ph.D., M.D., Professor, Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China, 444255018@qq.com.
  • About author:Teng Xie, M.D., Physician. Teng Xie and Jie Zhang contributed equally to this study.